1 December 2017

The ERC has announced the awarding of the Consolidator grants that go to 329 top researchers across Europe. The funding, part of the EU's Horizon 2020 programme, is worth in total €630 million and will give them a chance to have far-reaching impact on science and beyond.

We are very proud to announce that Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a prestigious ERC Consolidator grant
(€ 2 million) with his project entitled: A systems biology approach to investigate cell fate switches in intestinal organoids. The research of Michiel Vermeulen focuses on stem cells in the intestine.

Every day, our intestines produce over 200 grams of new cells. This large amount of cells is produced by so called adult stem cell, present in the walls of our intestines. These stem cells divide every day, but also differentiate into different cell types involved in processes, such as absorbing nutrients and excreting hormones and slime. When bowel cancer develops, the balance between cell division and cell differentiation is disturbed. The cancer stem cells can now divide uncontrollably and without differentiating. Recently, the possibility to culture different cells from the intestine, so called organoids, became available. Using these intestinal organoids, Vermeulen and his team will research this delicate balance between cell division and cell differentiation in detail.


 

 

Related news items


T cell immunity is directed by tetraspanin CD53

5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read more

A single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta

21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read more

Dutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs

14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read more

European grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant

26 April 2022

The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.

read more

Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation published in Cellular and Molecular Life Sciences

20 April 2022 Lisa Huis in ‘t Veld, Nataschja Ho and colleagues from the team of Gosse Adema published in Cellular and Molecular Life Sciences that Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation. read more

Rubicon grants awarded to three RIMLS researchers

19 April 2022 Three researchers have received Rubicon funding from NWO/ZonMw. This will enable Elke Muntjewerff, Laura de Vries and Laurens van de Wiel to do research at a foreign research institute for the next two years. read more